Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency - long-term survival of the GeparOLA studyPeter A. Fasching,Sabine Schmatloch,Jan Hauke, Julia Rey,Christian Jackisch,Peter Klare,Theresa Link,Claus Hanusch,Jens Huober,Andrea Stefek,Sabine Seiler,Wolfgang D. Schmitt,Christoph Uleer, Gabriele Doering,Kerstin Rhiem,Andreas Schneeweiss,Carsten Denkert,Rita K. Schmutzler,Eric Hahnen,Michael Untch,Valentina Nekljudova,Jens-Uwe Blohmer,Sibylle LoiblCANCER RESEARCH（2023）引用 1|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
